The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
2019 · Signal Transduction and Targeted Therapy · 690 citations
https://doi.org/10.1038/s41392-019-0099-9
L
Lili Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.5K
Citations
17
h-index
21
i10-index
Lili Huang is an academic researcher from Nantong University. The author has contributed to research in topics: Chronic Kidney Disease and Diabetes & Acute Kidney Injury Research & Cardiac, Anesthesia and Surgical Outcomes. The author has an h-index of 17, co-authored 38 publications.
ORCID: 0000-0002-6304-6511Papers by this author
worksDisrupted functional and structural connectivity within default mode network contribute to WMH-related cognitive impairment
2019 · NeuroImage Clinical · 66 citations
https://doi.org/10.1016/j.nicl.2019.102088
A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial
2022 · Critical Care · 18 citations
https://doi.org/10.1186/s13054-022-04120-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat